Lista de obras - Tania Bubela - Dominio Público Uruguay

"If they tell me to get it, I'll get it. If they don't...": Immunization decision-making processes of immigrant mothers.

artículo científico publicado en 2015

"Is a cure in my sight?" Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials

artículo científico publicado en 2013

AMP v. Myriad: A Surgical Strike on Blockbuster Business Models

artículo científico publicado en 2013

Access and benefits sharing of genetic resources and associated traditional knowledge in northern Canada: understanding the legal environment and creating effective research agreements

scientific article published on 05 August 2013

Application of protection motivation theory to clinical trial enrolment for pediatric chronic conditions

artículo científico publicado en 2020

Author name disambiguation for collaboration network analysis and visualization

scholarly article by Andreas Strotmann et al published 2009 in Proceedings of the American Society for Information Science and Technology

Automated content analysis as a tool for research and practice: a case illustration from the Prairie Creek and Nico environmental assessments in the Northwest Territories, Canada

article

Bringing regenerative medicines to the clinic: the future for regulation and reimbursement.

artículo científico publicado en 2015

Canada's Assisted Human Reproduction Act: Pragmatic Reforms in Support of Research

artículo científico publicado en 2019

Cell therapy licensing: a web for the unwary in Kimble v. Marvel Entertainment?

artículo científico publicado en 2016

Challenges for intellectual property management of HIV vaccine-related research and development: part 1, the global context

artículo científico publicado en 2008

Challenges for intellectual property management of HIV vaccine-related research and development: part 2, the Canadian context

artículo científico publicado en 2008

Choroideremia research: Report and perspectives on the second international scientific symposium for choroideremia

artículo científico publicado en 2016

Circumpolar stakeholder perspectives on Geographic Information Systems for communicating the health impacts of development

article

Commercialization and collaboration: competing policies in publicly funded stem cell research?

artículo científico publicado en 2010

Communicating the promise for ocular gene therapies: challenges and recommendations.

artículo científico

Creating a data resource: what will it take to build a medical information commons?

artículo científico publicado en 2017

Current practices and reform proposals for the regulation of advanced medicinal products in Canada

artículo científico publicado en 2015

DNA barcoding in the media: does coverage of cool science reflect its social context?

artículo científico publicado en 2016

Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers

artículo científico publicado en 2004

Drugs: Regulate 'home-brew' opiates

artículo científico publicado en 2015

Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation

artículo científico publicado en 2012

Factors affecting the trappability of red foxes in Kosciusko National Park

article

Fostering reproducibility in industry-academia research

artículo científico publicado en 2017

Gene patents—more evidence needed, but policymakers must act

article

Genetic Resources and Traditional Knowledge

article

Governance of a global genetic resource commons for non-commercial research: A case-study of the DNA barcode commons

artículo científico publicado en 2019

Herbal remedy clinical trials in the media: a comparison with the coverage of conventional pharmaceuticals

artículo científico publicado en 2008

Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol

artículo científico publicado en 2020

Implementing Socially Responsible Licensing for Global Health: Beyond Neglected Diseases

article

Importance of Participant-Centricity and Trust for a Sustainable Medical Information Commons

artículo científico publicado en 2019

Is belief larger than fact: expectations, optimism and reality for translational stem cell research

artículo científico publicado en 2012

Keeping score, strengthening policy and fighting bad actors over access to research tools.

artículo científico publicado en 2015

Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic.

artículo científico publicado en 2017

L'éthique de la modification du génome en clinique : une dose de réalisme pour les leaders en santé.

artículo científico publicado en 2017

Legal agreements and the governance of research commons: lessons from materials sharing in mouse genomics

artículo científico publicado en 2014

Lost in translation: the Canadian access to medicines regime from transnational activism to domestic implementation.

artículo científico publicado en 2010

Media portrayal of conflicts of interest in herbal remedy clinical trials.

artículo científico publicado en 2006

Medical Information Commons to Support Learning Healthcare Systems: Examples From Canada

article

Monitoring progress toward United Nations commitments: characteristics of Canadian legislation to promote tobacco control, physical activity and healthy eating. A descriptive study

scientific article published on 01 October 2019

More Haste, Less Speed: Could Public-Private Partnerships Advance Cellular Immunotherapies?

artículo científico publicado en 2017

Myriad and the mass media: the covering of a gene patent controversy

artículo científico publicado en 2007

Non-invasive Prenatal Testing and the Unveiling of an Impaired Translation Process

artículo científico publicado en 2016

Ocular gene transfer in the spotlight: implications of newspaper content for clinical communications

artículo científico publicado en 2014

Opportunities and challenges for the cellular immunotherapy sector: a global landscape of clinical trials.

artículo científico

Participant perspectives on a phase I/II ocular gene therapy trial (NCT02077361)

artículo científico publicado en 2019

Patent landscaping for life sciences innovation: toward consistent and transparent practices

artículo científico publicado en 2013

Patents and misplaced angst: lessons for translational stem cell research from genomics

artículo científico publicado en 2013

Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges.

artículo científico publicado en 2017

Post-publication sharing of data and tools

artículo científico publicado en 2009

Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making

artículo científico publicado en 2013

Provenance and risk in transfer of biological materials

artículo científico publicado en 2018

Recalibrating intellectual property rights to enhance translational research collaborations

artículo científico publicado en 2012

Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada

article

Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate

artículo científico publicado en 2013

Reproducibility and Reuse of Adaptive Immune Receptor Repertoire Data.

artículo científico publicado en 2017

Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications.

artículo científico publicado en 2017

Role and reality: technology transfer at Canadian universities

article

Science communication in transition: genomics hype, public engagement, education and commercialization pressures.

artículo científico publicado en 2006

Science communication reconsidered

article

Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment

artículo científico publicado en 2020

Stem cells, politics and the progress paradigm

scientific article published on 01 January 2006

Stepping Into and Out of the Void: Funding Dynamics of Human Embryonic Stem Cell Research in California, Sweden, and South Korea

artículo científico publicado en 2015

Sustaining large-scale infrastructure to promote pre-competitive biomedical research: lessons from mouse genomics.

artículo científico publicado en 2015

Synthetic biology confronts publics and policy makers: challenges for communication, regulation and commercialization.

artículo científico publicado en 2011

The Mouse That Trolled: The Long and Tortuous History of a Gene Mutation Patent That Became an Expensive Impediment to Alzheimer's Research

artículo científico publicado en 2015

The ethics of genome editing in the clinic: A dose of realism for healthcare leaders.

artículo científico publicado en 2017

The global landscape of stem cell clinical trials

artículo científico publicado en 2013

The mouse that trolled (again).

artículo científico publicado en 2016

The new age of the Nagoya Protocol

research work

The stem cell research environment: a patchwork of patchworks

artículo científico publicado en 2009

Use and misuse of material transfer agreements: lessons in proportionality from research, repositories, and litigation

artículo científico publicado en 2015

Value-engineered translation for regenerative medicine: meeting the needs of health systems.

artículo científico publicado en 2013

Value-engineered translation: developing biotherapeutics that align with health-system needs

When pictures waste a thousand words: analysis of the 2009 H1N1 pandemic on television news

artículo científico publicado en 2013

Why a criminal ban? Analyzing the arguments against somatic cell nuclear transfer in the Canadian parliamentary debate

artículo científico publicado en 2007

Lista de obras de Tania Bubela

"If they tell me to get it, I'll get it. If they don't...": Immunization decision-making processes of immigrant mothers.

"Is a cure in my sight?" Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials

AMP v. Myriad: A Surgical Strike on Blockbuster Business Models

Access and benefits sharing of genetic resources and associated traditional knowledge in northern Canada: understanding the legal environment and creating effective research agreements

Application of protection motivation theory to clinical trial enrolment for pediatric chronic conditions

Author name disambiguation for collaboration network analysis and visualization

Automated content analysis as a tool for research and practice: a case illustration from the Prairie Creek and Nico environmental assessments in the Northwest Territories, Canada

Bringing regenerative medicines to the clinic: the future for regulation and reimbursement.

Canada's Assisted Human Reproduction Act: Pragmatic Reforms in Support of Research

Cell therapy licensing: a web for the unwary in Kimble v. Marvel Entertainment?

Challenges for intellectual property management of HIV vaccine-related research and development: part 1, the global context

Challenges for intellectual property management of HIV vaccine-related research and development: part 2, the Canadian context

Choroideremia research: Report and perspectives on the second international scientific symposium for choroideremia

Circumpolar stakeholder perspectives on Geographic Information Systems for communicating the health impacts of development

Commercialization and collaboration: competing policies in publicly funded stem cell research?

Communicating the promise for ocular gene therapies: challenges and recommendations.

Creating a data resource: what will it take to build a medical information commons?

Current practices and reform proposals for the regulation of advanced medicinal products in Canada

DNA barcoding in the media: does coverage of cool science reflect its social context?

Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers

Drugs: Regulate 'home-brew' opiates

Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation

Factors affecting the trappability of red foxes in Kosciusko National Park

Fostering reproducibility in industry-academia research

Gene patents—more evidence needed, but policymakers must act

Genetic Resources and Traditional Knowledge

Governance of a global genetic resource commons for non-commercial research: A case-study of the DNA barcode commons

Herbal remedy clinical trials in the media: a comparison with the coverage of conventional pharmaceuticals

Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol

Implementing Socially Responsible Licensing for Global Health: Beyond Neglected Diseases

Importance of Participant-Centricity and Trust for a Sustainable Medical Information Commons

Is belief larger than fact: expectations, optimism and reality for translational stem cell research

Keeping score, strengthening policy and fighting bad actors over access to research tools.

Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic.

L'éthique de la modification du génome en clinique : une dose de réalisme pour les leaders en santé.

Legal agreements and the governance of research commons: lessons from materials sharing in mouse genomics

Lost in translation: the Canadian access to medicines regime from transnational activism to domestic implementation.

Media portrayal of conflicts of interest in herbal remedy clinical trials.

Medical Information Commons to Support Learning Healthcare Systems: Examples From Canada

Monitoring progress toward United Nations commitments: characteristics of Canadian legislation to promote tobacco control, physical activity and healthy eating. A descriptive study

More Haste, Less Speed: Could Public-Private Partnerships Advance Cellular Immunotherapies?

Myriad and the mass media: the covering of a gene patent controversy

Non-invasive Prenatal Testing and the Unveiling of an Impaired Translation Process

Ocular gene transfer in the spotlight: implications of newspaper content for clinical communications

Opportunities and challenges for the cellular immunotherapy sector: a global landscape of clinical trials.

Participant perspectives on a phase I/II ocular gene therapy trial (NCT02077361)

Patent landscaping for life sciences innovation: toward consistent and transparent practices

Patents and misplaced angst: lessons for translational stem cell research from genomics

Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges.

Post-publication sharing of data and tools

Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making

Provenance and risk in transfer of biological materials

Recalibrating intellectual property rights to enhance translational research collaborations

Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada

Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate

Reproducibility and Reuse of Adaptive Immune Receptor Repertoire Data.

Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications.

Role and reality: technology transfer at Canadian universities

Science communication in transition: genomics hype, public engagement, education and commercialization pressures.

Science communication reconsidered

Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment

Stem cells, politics and the progress paradigm

Stepping Into and Out of the Void: Funding Dynamics of Human Embryonic Stem Cell Research in California, Sweden, and South Korea

Sustaining large-scale infrastructure to promote pre-competitive biomedical research: lessons from mouse genomics.

Synthetic biology confronts publics and policy makers: challenges for communication, regulation and commercialization.

The Mouse That Trolled: The Long and Tortuous History of a Gene Mutation Patent That Became an Expensive Impediment to Alzheimer's Research

The ethics of genome editing in the clinic: A dose of realism for healthcare leaders.

The global landscape of stem cell clinical trials

The mouse that trolled (again).

The new age of the Nagoya Protocol

The stem cell research environment: a patchwork of patchworks

Use and misuse of material transfer agreements: lessons in proportionality from research, repositories, and litigation

Value-engineered translation for regenerative medicine: meeting the needs of health systems.

Value-engineered translation: developing biotherapeutics that align with health-system needs

When pictures waste a thousand words: analysis of the 2009 H1N1 pandemic on television news

Why a criminal ban? Analyzing the arguments against somatic cell nuclear transfer in the Canadian parliamentary debate